Morrow
M
Select, Recent Publications
Factors
influencing the use of breast reconstruction postmastectomy:
a National Cancer Database study.
Morrow
M, Scott SK, Menck HR, Mustoe TA, Winchester DP. Journal of
the American College of Surgeons. 2001;192:1-8.
Clinical
highlights from the National Cancer Data Base, 2000.
Stewart
AK, Bland KI, McGinnis LS Jr, Morrow M, Eyre HJ. Ca: a Cancer
Journal for Clinicians. 2000;50:171-83.
Symposium
overview: estrogens and antiestrogens in managing the patient
with breast cancer.
Newman
LA, Wood WC, Sellin RV, Morrow M, Vogel C, Singletary SE.
Annals of Surgical Oncology. 2000;7:568-74.
Treatment
selection in ductal carcinoma in situ.
Morrow
M, Schnitt SJ. JAMA. 2000;283:453-5.
Tamoxifen
for the prevention of breast cancer in the high-risk woman.
[Review].
Morrow
M, Jordan VC. Annals of Surgical Oncology. 2000;7:67-71.
Insurance
policies for prophylactic surgery: to cover or not to cover?
Morrow
M. Annals of Surgical Oncology. 2000;7:321-2.
Management
of complex breast cysts.
Venta
LA, Kim JP, Pelloski CE, Morrow M. American Journal of Roentgenology.
1999;173:1331-6.
Lobular
carcinoma in situ: current concepts and controversies. [Review].
Schnitt
SJ, Morrow M. Seminars in Diagnostic Pathology. 1999;16:209-23.
Learning
sentinel node biopsy: results of a prospective randomized
trial of two techniques.
Morrow
M, Rademaker AW, Bethke KP, et al. Surgery. 1999;126:714-20;
discussion 720-2.
Current
controversies in breast cancer management. [Review].
Morrow
M, Jordan VC, Takei H, Gradishar WJ, Pierce LJ. Current Problems
in Surgery. 1999;36:163-216.
Postmastectomy
radiation therapy: A surgical perspective. [Review].
Morrow
M. Seminars in Radiation Oncology. 1999;9:269-74.
Tamoxifen,
raloxifene, and the prevention of breast cancer. [Review].
Jordan
VC, Morrow M. Endocrine Reviews. 1999;20:253-78.
Consensus
Statement on postmastectomy radiation therapy. [Review].
Harris
JR, Halpin-Murphy P, McNeese M, Mendenhall NP, Morrow M, Robert
NJ. International Journal of Radiation Oncology, Biology,
Physics. 1999;44:989-90.
Hormone
replacement therapy and risk of breast cancer with a favorable
histology: results of the Iowa Women's Health Study [see comments].
Gapstur
SM, Morrow M, Sellers TA. JAMA. 1999;281:2091-7.
Impact
of same-day screening mammography availability: results of
a controlled clinical trial.
Dolan
NC, McDermott MM, Morrow M, Venta L, Martin GJ. Archives of
Internal Medicine. 1999;159:393-8.
The
effect of raloxifene on risk of breast cancer in postmenopausal
women: results from the MORE randomized trial. Multiple Outcomes
of Raloxifene Evaluation [see comments].
Cummings
SR, Eckert S, Krueger KA, et al. JAMA. 1999;281:2189-97.
Management
of axillary lymph nodes in breast cancer: a national patterns
of care study of 17,151 patients.
Brenin
DR, Morrow M, Moughan J, Owen JB, Wilson JF, Winchester DP.
Annals of Surgery. 1999;230:686-91.
The
evaluation of breast masses in women younger than forty years
of age.
Morrow
M, Wong S, Venta L. Surgery. 1998;124:634-40; discussion 640-1.
Breast
conservation for mammographically occult carcinoma.
Morrow
M, Schmidt RA, Bucci C. Annals of Surgery. 1998;227:502-6.
Medical
contraindications are not a major factor in the underutilization
of breast conserving therapy.
Morrow
M, Bucci C, Rademaker A. Journal of the American College of
Surgeons. 1998;186:269-74.
Breast
disease. [Review].
Hansen
N, Morrow M. Medical Clinics of North America. 1998;82:203-22.
Ductography
for nipple discharge: no replacement for ductal excision.
Dawes
LG, Bowen C, Venta LA, Morrow M. Surgery. 1998;124:685-91.
Evaluation
of common breast problems: guidance for primary care providers
[see comments].
Cady
B, Steele GD Jr, Morrow M, et al. Ca: a Cancer Journal for
Clinicians. 1998;48:49-63.
Breast-conserving
surgery in the neoadjuvant setting. [Review].
Brenin
DR, Morrow M. Seminars in Oncology. 1998;25:13-8.
Accuracy
of AJCC staging for breast cancer patients undergoing re-excision
for positive margins. American Joint Committee on Cancer.
Brenin
DR, Morrow M. Annals of Surgical Oncology. 1998;5:719-23.
The
National Cancer Data Base 10-year survey of breast carcinoma
treatment at hospitals in the United States.
Bland
KI, Menck HR, Scott-Conner CE, Morrow M, Winchester DJ, Winchester
DP. Cancer. 1998;83:1262-73.
Factors
responsible for the underutilization of breast conserving
therapy (BCT) (Meeting abstract).
Morrow
M, Winchester DP, Chmiel JS, et al. Proc Annu Meet Am Soc
Clin Oncol. 17:A379, 1998.
Identification
of the woman at risk for breast cancer: problem solved?. [Review].
Morrow M. Recent Results in Cancer Research 1999;151:85-95.
Incident
primary breast cancers are reduced by raloxifene: integrated
data from multicenter, double-blind, randomized trials in
[sim]12,000 postmenopausal women (Meeting abstract).
Jordan
VC, Glusman JE, Eckert S, et al. Proc Annu Meet Am Soc Clin
Oncol. 17:A466, 1998.
Do
risk factors differ between ductal carcinoma in situ (dcis)
and invasive breast cancers (Meeting abstract).
Gapstur
SM, Morrow M, Sellers TA. Proc Annu Meet Am Soc Clin Oncol.
17:A2156, 1998.
Current
management of axillary lymph nodes in breast cancer: a national
patterns of care study (Meeting abstract).
Brenin
DR, Morrow M, Moughan J, Owen J, Wilson JF, Winchester DP.
Proc Annu Meet Am Soc Clin Oncol. 17:A380, 1998.
|
